| FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
| |||||||||||||||
| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | |||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
| 2. Issuer Name and Ticker or Trading Symbol SECOND SIGHT MEDICAL PRODUCTS INC [ EYES ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
| ||||||||||||||||||||||||
| 3. Date of Earliest Transaction (Month/Day/Year) 01/04/2018 | ||||||||||||||||||||||||||
| 4. If Amendment, Date of Original Filed (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||||||||||||
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Common Stock | 172,911 | D | ||||||||
| Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Non-Qualified Stock Option (right to buy) | $2.06 | 01/04/2018 | A | 140,000 | 01/04/2019(1) | 01/04/2028 | Common Stock | 140,000 | (4) | 140,000 | D | ||||
| Non-Qualified Stock Option (right to buy) | $1.97 | 01/03/2018(2) | 01/03/2027 | Common Stock | 256,410 | 256,410 | D | ||||||||
| Non-Qualified Stock Option (right to buy) | $4.1 | 01/21/2017(2) | 01/21/2026 | Common Stock | 57,563 | 57,563 | D | ||||||||
| Non-Qualified Stock Option (right to buy) | $5 | 02/01/2009(3) | 02/01/2018 | Common Stock | 23,750 | 23,750 | D | ||||||||
| Non-Qualified Stock Option (right to buy) | $5 | 11/01/2009(3) | 11/01/2018 | Common Stock | 150,000 | 150,000 | D | ||||||||
| Non-Qualified Stock Option (right to buy) | $5 | 02/01/2010(3) | 02/01/2019 | Common Stock | 33,750 | 33,750 | D | ||||||||
| Non-Qualified Stock Option (right to buy) | $5 | 02/01/2011(3) | 02/01/2020 | Common Stock | 103,750 | 103,750 | D | ||||||||
| Non-Qualified Stock Option (right to buy) | $5 | 03/01/2012(3) | 03/01/2021 | Common Stock | 41,563 | 41,563 | D | ||||||||
| Non-Qualified Stock Option (right to buy) | $5 | 03/01/2013(3) | 03/01/2022 | Common Stock | 38,750 | 38,750 | D | ||||||||
| Non-Qualified Stock Option (right to buy) | $5 | 04/01/2015(3) | 04/01/2024 | Common Stock | 46,875 | 46,875 | D | ||||||||
| Non-Qualified Stock Option (right to buy) | $9 | 09/26/2015(3) | 09/26/2024 | Common Stock | 414,659 | 414,659 | D | ||||||||
| Non-Qualified Stock Option (right to buy) | $13.09 | 03/25/2016(3) | 03/25/2025 | Common Stock | 31,250 | 31,250 | D | ||||||||
| Explanation of Responses: |
| 1. The shares subject to this option shall vest and become exercisable at a rate of 25% of the total number of shares on the one-year anniversary of January 4, 2018 (the "Vesting Commencement Date") and 6.25% of the total number of shares shall vest each quarterly anniversary of the Vesting Commencement Date thereafter, for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date. |
| 2. Options vest over a four year term of which one-fourth vests on the Date Exercisable, with the remaining options vesting quarterly over three years thereafter. |
| 3. Options vest in 4 yearly increments starting with the Date Exercisable |
| 4. Not Applicable |
| /s/ Robert J Greenberg | 01/08/2018 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
